MedPath

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus

Registration Number
NCT02489968
Lead Sponsor
Boehringer Ingelheim
Brief Summary

Two independent study parts (i.e. Part A and Part B) are included in this trial. Part A will evaluate empagliflozin 10 mg + linagliptin and Part B will evaluate empagliflozin 25 mg + linagliptin. All analyses will be carried out separately for these study parts. The objective of Part A is to investigate the efficacy, safety and tolerability of the fixed dose combination (FDC) of empagliflozin 10 mg / linagliptin 5 mg compared with empagliflozin 10 mg plus FDC matching placebo administered orally once daily for 24 weeks in Japanese patients with T2DM (Type 2 Diabetes Mellitus) who have insufficient glycaemic control after 16 weeks of treatment with empagliflozin 10 mg alone once daily. The study is designed to show superiority of the FDC of empagliflozin 10 mg / linagliptin 5 mg over empagliflozin 10 mg plus FDC matching placebo after 24 weeks of treatment. The objective of Part B is to investigate the efficacy, safety and tolerability of the FDC of empagliflozin 25 mg / linagliptin 5 mg compared with empagliflozin 25 mg plus FDC matching placebo administered orally once daily for 24 weeks in Japanese patients with T2DM who have insufficient glycaemic control after 16 weeks of treatment with empagliflozin 25 mg alone once daily. The study is designed to show superiority of the FDC of empagliflozin 25 mg / linagliptin 5 mg over empagliflozin 25 mg plus FDC matching placebo after 24 weeks of treatment. The 24 week treatment period will be followed by a 28 week extension treatment period to evaluate further efficacy and safety up to 52 weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
880
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
empagliflozin 10 mg + linagliptin 5 mgempagliflozin 10 mg + linagliptin 5 mgpatient to receive a tablet containing low dose empagliflozin and linagliptin once daily
empagliflozin 25 mg + linagliptin 5 mgempagliflozin 25 mg + linagliptin 5 mgpatient to receive a tablet containing high dose empagliflozin and linagliptin once daily
empagliflozin 10 mgempagliflozin 10 mgpatient to receive a tablet containing low dose empagliflozin once daily
empagliflozin 25 mgempagliflozin 25 mgpatients to receive a tablet containing high dose empagliflozin once daily
empagliflozin 10 mgPlacebopatient to receive a tablet containing low dose empagliflozin once daily
empagliflozin 25 mgPlacebopatients to receive a tablet containing high dose empagliflozin once daily
Primary Outcome Measures
NameTimeMethod
Change in Glycated Haemoglobin A1c (HbA1c) (%) From Baseline After 24 Weeks of TreatmentBaseline and 24 week

Change from baseline in HbA1c (%) after 24 weeks of treatment with double-blind trial medication. Change was calculated as: HbA1c value at 24-week - HbA1c value at baseline, for each patient. Baseline was defined as the last observation before the first intake of double-blind randomised trial medication. Statistical analysis presented is based on a restricted maximum likelihood (REML)-based mixed model repeated measures (MMRM) approach. Full Analysis Set (Observed Cases) \[FAS (OC)\]: This analysis set consisted of all patients who were randomised and treated with at least 1 dose of trial drug during the double-blind part of the trial and who had a baseline HbA1c assessment and at least 1 on-treatment HbA1c assessment during the 24-week double-blind part of the trial. Observed cases analysis included only the available data that were observed while patients were on treatment, i.e., excluding the missing data.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (83)

Ebetsu Internal Medicine Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Hokkaido, Ebetsu, Japan

Iida Medical Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Hokkaido, Hakodate, Japan

Morinagaueno clinic, Kumamoto, Digestive Tract I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Kumamoto, Kumamoto, Japan

AGE Makita Medical Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Chuo-ku, Japan

Kanda Clinic, Tokyo, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Japan

Shin Yukuhashi Hospital

๐Ÿ‡ฏ๐Ÿ‡ต

Fukuoka, Yukuhashi, Japan

Odayaka Life Naika Clinic, Saitama, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Saitama, Koshigaya, Japan

Hamamatsu Rosai Hospital

๐Ÿ‡ฏ๐Ÿ‡ต

Shizuoka, Hamamatsu, Japan

Nihonbashi Sakura Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Chuo-ku, Japan

Fukuwa Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Chuo-ku, Japan

Kikuchi Naika Clinic, Gunma, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Gunma, Maebashi, Japan

Manda Memorial Hospital

๐Ÿ‡ฏ๐Ÿ‡ต

Hokkaido, Sapporo, Japan

Japan Community Health Care Organization Hokkaido Hospital

๐Ÿ‡ฏ๐Ÿ‡ต

Hokkaido, Sapporo, Japan

Kumamoto University Hospital

๐Ÿ‡ฏ๐Ÿ‡ต

Kumamoto, Kumamoto, Japan

Clinic Sugiyama, Yamagata, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Yamagata, Yamagata, Japan

Tokai Memorial Hospital

๐Ÿ‡ฏ๐Ÿ‡ต

Aichi, Kasugai, Japan

Japan Organization of Occupational Health and Safety Chubu Rosai Hospital

๐Ÿ‡ฏ๐Ÿ‡ต

Aichi, Nagoya, Japan

Kunisaki Makoto Clinic, Fukuoka, I.M./CV Med.

๐Ÿ‡ฏ๐Ÿ‡ต

Fukuoka, Fukuoka, Japan

Fukuoka Shin Mizumaki Hospital

๐Ÿ‡ฏ๐Ÿ‡ต

Fukuoka, Onga, Japan

Hashimoto I.M., Gifu, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Gifu, Gifu, Japan

Hasegawa Internal Medicine Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Hokkaido, Chitose, Japan

Honda Hidehiko Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Ota-ku, Japan

Murakami Memorial Hp., Ehime, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Ehime, Saijo, Japan

Hakodate Koseiin Hakodate Central General Hospital

๐Ÿ‡ฏ๐Ÿ‡ต

Hokkaido, Hakodate, Japan

Uehara Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Hokkaido, Sapporo, Japan

Namegata District General Hospital

๐Ÿ‡ฏ๐Ÿ‡ต

Ibaraki, Namegata, Japan

Oikawa Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Iwate, Morioka, Japan

Hirano Medical Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Iwate, Morioka, Japan

Tokuyama Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Chiba, Chiba, Japan

Tanaka Int. Clinic, Ehime, DIA Med.,CV Med.

๐Ÿ‡ฏ๐Ÿ‡ต

Ehime, Niihama, Japan

Kurihara Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Hokkaido, Sapporo, Japan

Sapporo Diabetes, Thyroid Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Hokkaido, Sapporo, Japan

Hokuriku Hp., Ishikawa, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Ishikawa, Kanazawa, Japan

Ashiya Municipal Hospital

๐Ÿ‡ฏ๐Ÿ‡ต

Hyogo, Ashiya, Japan

Itabashi DIA Med. and DERM Clinic, Ibaraki, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Ibaraki, Koga, Japan

Takai Naika Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Kanagawa, Kamakura, Japan

Nagatsuta Family Clinic, Kanagawa, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Kanagawa, Yokohama, Japan

Jinnouchi Clinic Diabetes Care Center

๐Ÿ‡ฏ๐Ÿ‡ต

Kumamoto, Kumamoto, Japan

Iwamoto Clinic, Kagawa, DIAB I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Kagawa, Zentsuji, Japan

Tenpozan Clinic of I.M., Kagoshima, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Kagoshima, Kagoshima, Japan

Hayashi DIA Clinic, Kanagawa, DIA Tract Med.ยทI.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Kanagawa, Chigasaki, Japan

Motomachi Takatsuka Naika Clinic, Kanagawa, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Kanagawa, Yokohama, Japan

Kajiyama Clinic, Kyoto, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Kyoto, Kyoto, Japan

Matsumoto Nakagawa Hospital

๐Ÿ‡ฏ๐Ÿ‡ต

Nagano, Matsumoto, Japan

Saiseikai Niigata Daini Hp., Niigata, METAB ENDO

๐Ÿ‡ฏ๐Ÿ‡ต

Niigata, Niigata, Japan

Tsuyama Chuo Hospital

๐Ÿ‡ฏ๐Ÿ‡ต

Okayama, Tsuyama, Japan

Yokohama Minoru Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Kanagawa, Yokohama, Japan

Ota DIA I.M. Clinic, Nagano, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Nagano, Nagano, Japan

Nanko Clinic, Osaka, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Osaka, Osaka, Japan

Yaesu Clinic, Okinawa, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Okinawa, Naha, Japan

Tanaka Clinic, Okinawa, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Okinawa, Tomigusuku, Japan

Umeda Oak Clinic, Osaka, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Osaka, Osaka, Japan

Ikeoka Clinic, Osaka, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Osaka, Osaka, Japan

Shiraiwa Medical Clinic, Osaka, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Osaka, Japan

Medical corporation Chisei-kai Watanabe clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Saitama, Okegawa, Japan

Kinugawa CARDIOL Clinic, Osaka, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Osaka, Osaka, Japan

OCROM Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Osaka, Suita, Japan

AMC Nishi-umeda Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Osaka, Japan

Saga Memorial Hospital

๐Ÿ‡ฏ๐Ÿ‡ต

Saga, Saga, Japan

SAINO Clinic,

๐Ÿ‡ฏ๐Ÿ‡ต

Saitama, Tokorozawa, Japan

Shinkoiwa Ekimae Sougou Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Katushika-ku, Japan

Plumeria Clinic, Shizuoka, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Shizuoka, Shizuoka, Japan

Wakakusa Clinic, Tochigi, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Tochigi, Shimotsuke, Japan

Nihonbashi Enomoto Internal Medicine

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Chuo-ku, Japan

New Medical Research System Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Hachioji, Japan

Medical Corporation Keikokai P1-Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Hachioji, Japan

Minamino Heart Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Hachioji, Japan

Hosono Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Chuo-ku, Japan

Shinagawa East one Medical Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Minato-ku, Japan

Kasai Diabetes Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Edogawa-ku, Japan

Musashino Polyclinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Kiyose, Japan

Miho Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Shinagawa-ku, Japan

Shimamura Kinen Hospital

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Nerima-ku, Japan

Kenkoukan Suzuki Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Ota-ku, Japan

Sakayori Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Shinagawa-ku, Japan

ToCROM Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Shinjuku-ku, Japan

Ikebukuro Metropolitan Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Toshima-ku, Japan

Fujikoshi Hp., Toyama, I.M.

๐Ÿ‡ฏ๐Ÿ‡ต

Toyama, Toyama, Japan

Matsuyama Shimin Hospital

๐Ÿ‡ฏ๐Ÿ‡ต

Ehime, Matsuyama, Japan

Medical Corporation Toujinkai Sakado Central Hospital

๐Ÿ‡ฏ๐Ÿ‡ต

Saitama, Sakado, Japan

Tokyo-Eki Center-building Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Chuo-ku, Japan

Tokyo Center Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Chuo-ku, Japan

Pedi Shiodome Clinic

๐Ÿ‡ฏ๐Ÿ‡ต

Tokyo, Minato-ku, Japan

ยฉ Copyright 2025. All Rights Reserved by MedPath